FSSAI License for Health Supplements & Nutraceuticals: Foreign Brand Guide

Why Foreign Brands Are Entering India's Nutraceuticals Market

Nutraceuticals are among the most strictly regulated product categories under FSSAI. Unlike general food products, where a State License may suffice, all nutraceutical and health supplement manufacturers must obtain an FSSAI Central License regardless of production capacity.

This is a unique sector-specific mandate that catches many foreign entrants off guard. India's nutraceuticals and health supplements market has been expanding quickly, driven by rising health consciousness, increasing disposable incomes, and a growing fitness culture; published growth-rate estimates vary widely between research houses, so treat any single figure with caution when sizing an investment case. The market offers significant whitespace for international brands with established product portfolios, clinical research backing, and premium positioning.

The Indian government permits 100% foreign direct investment (FDI) in the food processing sector through the automatic route, and nutraceuticals fall under this category. This means no prior government approval is needed — a foreign brand can establish a manufacturing unit, import finished products, or contract-manufacture in India with full foreign ownership.

Regulatory Framework: FSS (Health Supplements, Nutraceuticals) Regulations

The primary regulation governing this sector is the Food Safety and Standards (Health Supplements, Nutraceuticals, Food for Special Dietary Use, Food for Special Medical Purpose, Functional Food, and Novel Food) Regulations, 2016, as amended — the amendment regulations reworked the permitted dosage forms and the botanical schedule.

Product Categories Defined by FSSAI

Understanding which category your product falls into is the first critical decision, as it determines the approval pathway:

Key Amendment Changes

The amendment regulations introduced several changes foreign brands must understand:

• Dosage formats such as tablets, capsules and syrups are permitted for combinations of vitamins and minerals — including a single vitamin or mineral — at levels up to one Recommended Dietary Allowance; that provision was inserted by amendment with effect from 6 September 2021
• Schedule IV (the list of plant or botanical ingredients) was revised with updated permitted daily usage ranges
• Stricter labelling requirements for health claims and ingredient declarations
• Enhanced quality testing requirements at NABL-accredited laboratories

Why Central License Is Mandatory for All Nutraceuticals

Unlike other food categories where the licensing tier depends on turnover or production capacity, FSSAI mandates a Central License for all nutraceutical and health supplement businesses — whether manufacturer, importer, or marketer. This applies regardless of:

• Annual turnover — FSSAI's kind-of-business eligibility criteria list food or health supplements and nutraceuticals as "no restriction on turnover threshold", Central License
• Production volume (even small-batch manufacturing)
• Geographic scope (even single-state operations)

The licence is issued by a Central Licensing Authority — FSSAI, through its headquarters and regional offices — not by the state food safety department. The annual fee is INR 7,500. Since the Food Safety and Standards (Licensing and Registration of Food Businesses) Amendment Regulations, 2026 (notified 10 March 2026) substituted regulation 2.1.7, the licence is valid and subsisting until it is suspended, cancelled or surrendered; there is no fixed one-to-five-year term to buy up front, but the annual fee must be paid each year or the licence is deemed suspended until the fee and the applicable penalty are cleared.

Three Market Entry Pathways for Foreign Brands

A foreign brand has three primary routes to enter India's nutraceuticals market, each with different licensing implications:

Pathway 1: Direct Import and Distribution

The foreign brand manufactures abroad and imports finished products into India through an Indian importer entity.

• Requires: Indian entity (subsidiary or distributor) with FSSAI Central License for import
• Requires: Import Export Code (IEC) from DGFT
• Requires: Foreign Food Manufacturing facility registration on FSSAI's ReFoM portal
• Every consignment cleared through FSSAI-designated ports with sampling and testing
• Products must comply with Indian labelling standards — relabelling with FSSAI-compliant labels is mandatory

Pathway 2: Contract Manufacturing in India

The foreign brand contracts an Indian manufacturer to produce under its brand name.

• The contract manufacturer must hold their own FSSAI Central License
• The brand owner (foreign entity's Indian subsidiary) also needs an FSSAI license as a marketer/relabeller
• A Manufacturer Authorization / No Objection Certificate (NOC) from the contract manufacturer is required
• Both entities share compliance responsibility

Pathway 3: Own Manufacturing Facility

The foreign brand establishes its own manufacturing unit in India through a wholly-owned subsidiary or private limited company.

• Requires: FSSAI Central License for manufacturing
• Requires: GMP (Good Manufacturing Practice) certified facility
• Requires: In-house or contracted NABL-accredited testing laboratory
• Full control over formulation, quality, and supply chain
• Highest initial investment but lowest ongoing per-unit compliance cost

Ingredient Approval: The Critical Gate

The most common obstacle foreign brands face is ingredient approval. FSSAI maintains strict lists of permitted ingredients, and any deviation triggers a separate approval process.

Permitted Ingredients (the Schedules)

The 2016 Regulations carry the approved ingredient lists in their schedules — the list of vitamins and minerals and their components in Schedule I, amino acids and other nutrients in Schedule II, the values for vitamins, minerals and trace elements allowed in foods for special dietary use and foods for special medical purpose in Schedule III, and the list of plant or botanical ingredients in Schedule IV. Later schedules cover nutraceutical ingredients, enzymes, probiotic micro-organisms and prebiotic compounds; check the schedule numbering against the current compendium, because the schedules have been amended repeatedly. If every ingredient in your product appears in the relevant schedule at a permitted dosage level, the licensing process is straightforward — file Form B with standard documentation.

Non-Specified Food (NSF) Approval

If your product contains any ingredient not listed in FSSAI's approved schedules, or without a documented history of safe use in India, you must obtain Non-Specified Food (NSF) approval under the Food Safety and Standards (Approval of Non-Specified Food and Food Ingredients) Regulations, 2017, made under section 22 of the Food Safety and Standards Act, 2006. The application is made separately to FSSAI headquarters, and product approval must be in hand before you apply for the licence — FSSAI's own eligibility criteria say so expressly. Separate application routes exist for a single non-specified ingredient and for a complete non-specified food product or formulation; use the current forms prescribed under the 2017 Regulations. The NSF approval process requires:

• Detailed toxicological studies demonstrating safety
• Documentation of traditional usage history (if applicable)
• Comprehensive scientific literature review
• Expert committee review by FSSAI's Scientific Panel
• Processing timeline: 4 to 6 months (and frequently longer)

Foreign brands accustomed to US FDA GRAS (Generally Recognized as Safe) status should note that FSSAI does not automatically recognise FDA, EFSA, or TGA approvals. Each ingredient must be separately evaluated under Indian regulations.

Step-by-Step FSSAI Licensing Process for Nutraceuticals

Step 1: Incorporate an Indian Entity

Register a foreign subsidiary or private limited company with the Ministry of Corporate Affairs. File FC-GPR with the RBI within 30 days of allotting the shares. This typically takes 15-20 business days.

Step 2: Obtain IEC (If Importing)

Apply for an Import Export Code from the DGFT through the DGFT portal. Processing time is 3-5 business days.

Step 3: Register Foreign Manufacturing Facility (If Importing)

If importing finished products, the overseas manufacturing facility must register on FSSAI's Registration of Foreign Food Manufacturing Facilities (ReFoM) system, applying in Form 16 under regulation 18 of the Food Safety and Standards (Import) Regulations, 2017. Registration runs for two years and renewal must be filed in the same form not later than thirty days before expiry. This requires GMP certification, manufacturing license from the country of origin, and product testing reports.

Step 4: Verify Ingredient Compliance

Cross-check every ingredient and its dosage level against FSSAI's permitted schedules. If any ingredient requires NSF approval, initiate that process immediately as it takes 4-6 months.

Step 5: File Form B on FoSCoS

Apply for the Central License on the FoSCoS portal (foscos.fssai.gov.in). Key documents to upload:

• Certificate of Incorporation, MoA, AoA
• GST registration
• IEC (for importers)
• Product formulation details with exact ingredient quantities
• Certificate of Analysis (CoA) from an NABL-accredited lab
• Label artwork compliant with FSSAI labelling regulations
• GMP certificate of the manufacturing facility
• Manufacturer NOC or authorisation letter (for contract manufacturing/relabelling)
• Stability testing data

Step 6: Scrutiny and Inspection

FSSAI scrutinises the application for ingredient compliance, label accuracy, and documentation completeness. For manufacturing units, a physical facility inspection is conducted. Total processing time: 60-90 days.

Step 7: License Issuance

Upon satisfactory review, FSSAI issues the Central License with a 14-digit license number. This number must appear on every product label.

Labelling Requirements for Nutraceuticals

FSSAI labelling rules for nutraceuticals are significantly more detailed than for regular food products:

• Product name: Must clearly identify the product category (Health Supplement, Nutraceutical, etc.)
• Ingredient list: Complete list in descending order of weight/volume
• Nutritional information: Per serving and per 100g/100ml
• Recommended daily dosage: Clearly stated, not exceeding RDA limits
• Health claims: Only FSSAI-approved health claims are permitted; no disease treatment claims
• Warning statements: "Not for medicinal use" and "This product is not intended to diagnose, treat, cure, or prevent any disease"
• FSSAI license number: 14-digit number with FSSAI logo
• Vegetarian/Non-vegetarian symbol: Green dot (veg) or brown dot (non-veg)
• Best before date and batch number
• Country of origin: Mandatory for imported products
• Allergen declaration: All major allergens must be highlighted

Foreign brands frequently make the mistake of using their existing international labels with a simple sticker overlay. FSSAI requires full Indian-compliant labels — a complete redesign is almost always necessary.

Advertising and Claims Restrictions

The Food Safety and Standards (Advertising and Claims) Regulations, 2018, as amended, impose strict limits on how nutraceuticals can be marketed in India:

• No claims of curing, treating, or mitigating any disease
• Health claims must be pre-approved by FSSAI and substantiated with scientific evidence
• Comparative claims against other products are restricted
• No endorsements by medical professionals in advertising
• Digital and social media advertising must comply with the same standards

Misleading advertisements and false claims are penalised under sections 52 and 53 of the FSS Act, 2006, and can also cost you the licence. For foreign brands accustomed to more permissive advertising environments, this is a significant adjustment area.

Penalties for Non-Compliance

FSSAI enforcement in the nutraceuticals space has intensified significantly since 2022, and the penalty provisions themselves were rewritten by the Jan Vishwas (Amendment of Provisions) Act, 2023 (assented on 11 August 2023). Several offences were decriminalised into monetary penalties and the amounts were revised, so rupee figures published before that amendment — including the widely repeated "six months and INR 5 lakh" for trading without a licence — are out of date. The exposures that matter for a supplements business are:

• Carrying on business without a licence (s. 63): now a monetary penalty adjudicated by the Adjudicating Officer, with no imprisonment
• Sub-standard food (s. 50) and misbranded food (s. 51): monetary penalties
• Misleading advertisement or false claim (s. 52, s. 53): monetary penalties, and the most commonly used provision against overstated health claims
• Failure to comply with a Food Safety Officer's direction (s. 58 general penalty): monetary penalty
• Sale of unsafe food (s. 59): still a criminal offence, graded by the harm caused

Check the current amounts in the amended Act before relying on a figure.

For a foreign-invested entity, regulatory violations also create complications with FEMA/RBI compliance and can adversely impact the company's ability to repatriate profits or raise additional FDI.

Timeline and Cost Summary

The prescribed government fees aside, the professional and other costs below are illustrative planning ranges, not published survey data.

For products with all FSSAI-approved ingredients, the total timeline from company incorporation to market launch is approximately 4-5 months. If NSF approval is needed, this extends to 8-12 months.

Common Mistakes Foreign Brands Make

• Assuming FDA/EFSA approval transfers to India: FSSAI has its own ingredient approval framework — international approvals do not automatically apply
• Filing for State License instead of Central: All nutraceutical businesses require Central License regardless of turnover or capacity
• Insufficient stability data: FSSAI may reject applications without accelerated and real-time stability testing data for the product
• Non-compliant labels: International labels almost never meet FSSAI's detailed requirements — plan for a complete label redesign
• Ignoring advertising regulations: Marketing claims that are legal in the US, EU, or Australia may violate Indian advertising regulations
• Delaying NSF approval: If any ingredient needs non-specified food approval, start this process before anything else — it is the longest lead-time item

For broader guidance on navigating the FoSCoS portal and FSSAI registration requirements, see our detailed guides.

Key Takeaways

• All nutraceutical and health supplement businesses — manufacturers, importers, and marketers — must obtain an FSSAI Central License regardless of turnover or production volume
• The regulatory framework is the FSS (Health Supplements, Nutraceuticals) Regulations, 2016 as amended
• Ingredient approval is the critical gate — products with non-listed ingredients require NSF approval (4-6 months additional)
• Foreign brands have three entry pathways: direct import, contract manufacturing, or own factory — each with different licensing requirements
• FSSAI labelling and advertising regulations are significantly stricter than US/EU norms — plan for complete label redesign and marketing compliance review
• Total timeline ranges from 4-5 months (approved ingredients) to 8-12 months (with NSF approval)